首頁 > 市場調查報告書 > 製藥

生物製劑分子標靶治療學

歐洲抗體發現市場預測至 2030 年 - 區域分析 - 按抗體類型、性質、服務和最終用戶

市場調查報告書

商品編碼

1592596

歐洲抗體發現市場預測至 2030 年 - 區域分析 - 按抗體類型、性質、服務和最終用戶

Europe Antibody Discovery Market Forecast to 2030 - Regional Analysis - by Antibody Type, Nature, Services, and End User

出版日期: 2024年09月16日 | 出版商:

The Insight Partners | 英文 94 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年歐洲抗體發現市值為8,244.4111億美元，預計2030年將達到1,3294.816億美元；預計2022年至2030年複合年成長率為6.2%。

癌症發生率上升推動歐洲抗體發現市場

根據全球癌症觀察站 (GLOBOCAN) 2020 年發布的估計，全球有 1,930 萬癌症病例。到 2030 年 1 月，癌症倖存者人數預計將達到 2,210 萬，這主要與人口老化有關。肺癌、乳癌、大腸癌、攝護腺癌和乳癌是最常見的癌症類型。癌症發生率的上升引起了全世界的關注。以下是 2020 年全球報告的常見癌症病例清單。

2020 年全球新癌症病例

先生。

癌症類型

案件數量（百萬）

1. 胃
1.09
2. 皮膚（非黑色素瘤）
1.2
3.前列腺
1.41
4.結腸和直腸
1.93
5. 肺
2.21
6. 乳房
2.26

資料來源：世界衛生組織，2020 年 2 月

癌症現在是一種生活方式疾病，常見於飲食習慣不健康和缺乏體能活動的人。經常飲酒和吸煙會增加患癌症的風險。低收入和中等收入國家的慢性傳染病可進一步加劇癌症危險因子。癌症發生率的激增表明需要創新的癌症治療方法。單株抗體是一類有前景的標靶抗癌藥物，可增強免疫系統抑制癌細胞活性和消除癌細胞的天然能力。抗體藥物偶聯物（ADC）在癌症治療中也顯示出有希望的結果。此外，現代生物技術的進步使研究人員和公司能夠提供精心設計的新型抗體，為成功治療各種類型的癌症鋪平道路。因此，不同類型癌症發生率的迅速上升促進了抗體發現市場的成長。

歐洲抗體發現市場概況

歐洲抗體發現市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。該地區在全球市場中佔有重要佔有率。由於單株抗體在研發應用、癌症治療和免疫疾病管理的使用激增，預計未來幾年將強勁成長。此外，對患者資料管理系統的需求不斷成長、慢性病的流行以及政府實施抗體服務的舉措預計將為法國、義大利和西班牙等國家的抗體發現市場提供成長機會。

歐洲抗體發現市場收入及 2030 年預測（十億美元）

歐洲抗體發現市場細分

歐洲抗體發現市場按抗體類型、性質、服務、最終用戶和國家分類。

根據抗體類型，歐洲抗體發現市場分為單株抗體、多株抗體等。到 2022 年，單株抗體領域將佔據歐洲最大的抗體發現市場。

就性質而言，歐洲抗體發現市場分為人類和人源化、嵌合和鼠類。到 2022 年，人類和人源化細分市場將佔據歐洲最大的抗體發現市場。

依服務分類，歐洲抗體發現市場分為噬菌體展示、雜交瘤、基因改造動物、單細胞和酵母展示。到 2022 年，噬菌體展示領域將佔據歐洲最大的抗體發現市場。

根據最終用戶，歐洲抗體發現市場分為製藥和生技公司、研究實驗室等。到 2022 年，製藥和生物技術公司領域將佔據歐洲最大的抗體發現市場。

根據國家/地區，歐洲抗體發現市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。 2022 年，德國在歐洲抗體發現市場佔有率中佔據主導地位。

Charles River Laboratories International Inc、Creative Biolabs Inc、Evotec SE、Sartorius AG、Aragen Life Sciences Ltd、Twist Bioscience Corp 和 Biocytogen Pharmaceuticals 北京有限公司是歐洲抗體發現市場上的一些領先公司。

As per the Global Cancer Observatory (GLOBOCAN) estimates published in 2020, there were 19.3 million cancer cases across the world. By January 2030, the population of cancer survivors is estimated to reach 22.1 million, which can be primarily associated with the aging of the population. Lung, breast, colorectal, prostate, and breast are among the most commonly reported cancer types. The rising incidences of cancer have raised concerns worldwide.

Cancer is now a lifestyle disease commonly seen among people with unhealthy eating habits and those who don't engage much in physical activities. The frequent consumption of alcohol and tobacco adds up to the risk of developing cancer. Chronic infectious diseases in low- and middle-income countries can further aggravate the cancer risk factors. An upsurge in the incidence of cancer indicates the need for innovative cancer treatments. Monoclonal antibodies represent a promising class of targeted anticancer agents that enhance the natural ability of immune systems to suppress cancer cell activity and eliminate cancer cells. Antibody-drug conjugates (ADCs) have also shown promising results in cancer treatment. Further, progress in modern biotechnology allows researchers and companies to provide well-designed novel antibodies, paving the way for successful treatments of various types of cancer. Thus, the burgeoning incidence of different types of cancer boosts the antibody discovery market growth.

Europe Antibody Discovery Market Overview

The European antibody discovery market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant share of the global market. It is expected to register a robust growth rate in the coming years owing to the surging use of monoclonal antibodies in R&D applications, cancer therapies, and immunological disorder management. Further, the rising need for patient data management systems, the prevalence of chronic diseases, and government initiatives for the implementation of antibody services are expected to provide growth opportunities for the antibody discovery market in countries such as France, Italy, and Spain.

Europe Antibody Discovery Market Revenue and Forecast to 2030 (US$ Billion)

Europe Antibody Discovery Market Segmentation

The Europe antibody discovery market is categorized into antibody type, nature, services, end user, and country.

Based on antibody type, the Europe antibody discovery market is segmented into monoclonal antibodies, polyclonal antibodies, and others. The monoclonal antibodies segment held the largest Europe antibody discovery market share in 2022.

In terms of nature, the Europe antibody discovery market is segmented into human and humanized, chimeric, and murine. The human and humanized segment held the largest Europe antibody discovery market share in 2022.

By services, the Europe antibody discovery market is divided into phage display, hybridoma, transgenic animal, single cell, and yeast display. The phage display segment held the largest Europe antibody discovery market share in 2022.

Based on end user, the Europe antibody discovery market is categorized into pharmaceutical and biotechnology companies, research laboratories, and others. The pharmaceutical and biotechnology companies segment held the largest Europe antibody discovery market share in 2022.

Based on country, the Europe antibody discovery market is categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe antibody discovery market share in 2022.

Charles River Laboratories International Inc, Creative Biolabs Inc, Evotec SE, Sartorius AG, Aragen Life Sciences Ltd, Twist Bioscience Corp, and Biocytogen Pharmaceuticals Beijing Co Ltd. are some of the leading companies operating in the Europe antibody discovery market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Antibody Discovery Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Increasing Investments in Research & Development
- 4.1.2 Rising Incidence of Cancer
4.2 Market Restraints
- 4.2.1 High Cost of Production
4.3 Market Opportunities
- 4.3.1 Proliferation of Biotechnology Industry in Developing Regions
4.4 Future Trends
- 4.4.1 Developments for Custom Antibodies
4.5 Impact of Drivers and Restraints:

5. Antibody Discovery Market - Europe Market Analysis

5.1 Europe Antibody Discovery Market Revenue (US$ Million), 2020-2030

6. Europe Antibody Discovery Market Analysis - by Antibody Type

6.1 Overview
6.2 Monoclonal Antibodies
- 6.2.1 Overview
- 6.2.2 Monoclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Polyclonal Antibodies
- 6.3.1 Overview
- 6.3.2 Polyclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Others
- 6.4.1 Overview
- 6.4.2 Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Antibody Discovery Market Analysis - by Nature

7.1 Overview
7.2 Human and Humanized
- 7.2.1 Overview
- 7.2.2 Human and Humanized: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Chimeric
- 7.3.1 Overview
- 7.3.2 Chimeric: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Murine
- 7.4.1 Overview
- 7.4.2 Murine: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Antibody Discovery Market Analysis - by Services

8.1 Overview
8.2 Phage Display
- 8.2.1 Overview
- 8.2.2 Phage Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Hybridoma
- 8.3.1 Overview
- 8.3.2 Hybridoma: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Transgenic Animal
- 8.4.1 Overview
- 8.4.2 Transgenic Animal: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Yeast Display
- 8.5.1 Overview
- 8.5.2 Yeast Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Single Cell
- 8.6.1 Overview
- 8.6.2 Single Cell: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Antibody Discovery Market Analysis - by End User

9.1 Overview
9.2 Pharmaceutical and Biotechnology Companies
- 9.2.1 Overview
- 9.2.2 Pharmaceutical and Biotechnology Companies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Research Laboratories
- 9.3.1 Overview
- 9.3.2 Research Laboratories: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Antibody Discovery Market - Country Analysis

10.1 Europe Antibody Discovery Market, Revenue and Forecast to 2030
- 10.1.1 Europe: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 UK
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 UK: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.3 UK: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.1.4 UK: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.1.5 UK: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.1.6 UK: Antibody Discovery Market Breakdown, by End User
  - 10.1.1.2 Germany
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Germany: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.3 Germany: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.2.4 Germany: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.2.5 Germany: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.2.6 Germany: Antibody Discovery Market Breakdown, by End User
  - 10.1.1.3 France
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 France: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.3 France: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.3.4 France: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.3.5 France: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.3.6 France: Antibody Discovery Market Breakdown, by End User
  - 10.1.1.4 Italy
    - 10.1.1.4.1 Overview
    - 10.1.1.4.2 Italy: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.3 Italy: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.4.4 Italy: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.4.5 Italy: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.4.6 Italy: Antibody Discovery Market Breakdown, by End User
  - 10.1.1.5 Spain
    - 10.1.1.5.1 Overview
    - 10.1.1.5.2 Spain: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.5.3 Spain: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.5.4 Spain: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.5.5 Spain: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.5.6 Spain: Antibody Discovery Market Breakdown, by End User
  - 10.1.1.6 Rest of Europe
    - 10.1.1.6.1 Overview
    - 10.1.1.6.2 Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.6.3 Rest of Europe: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.6.4 Rest of Europe: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.6.5 Rest of Europe: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.6.6 Rest of Europe: Antibody Discovery Market Breakdown, by End User

11. Antibody Discovery Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Antibody Discovery Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Charles River Laboratories International Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Creative Biolabs Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Evotec SE
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Sartorius AG
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Aragen Life Sciences Ltd
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Twist Bioscience Corp
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Biocytogen Pharmaceuticals Beijing Co Ltd
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Europe Antibody Discovery Market Segmentation
Table 2. New Cancer Cases Worldwide, in 2020
Table 3. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 4. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 5. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 6. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 7. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 8. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 9. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 10. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 11. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 12. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 13. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 14. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 16. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 17. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 18. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 19. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 20. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 21. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 22. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 23. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 24. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 25. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 26. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 27. Recent Inorganic Growth Strategies in the Antibody Discovery Market
Table 28. Recent Organic Growth Strategies in the Antibody Discovery Market
Table 29. Glossary of Terms, Antibody Discovery Market

List Of Figures

Figure 1. Europe Antibody Discovery Market Segmentation, by Country
Figure 2. Europe Antibody Discovery Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Antibody Discovery Market Revenue (US$ Million), 2020 - 2030
Figure 5. Europe Antibody Discovery Market Share (%) - by Antibody Type (2022 and 2030)
Figure 6. Monoclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Polyclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Europe Antibody Discovery Market Share (%) - by Nature (2022 and 2030)
Figure 10. Human and Humanized: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Chimeric: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Murine: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Europe Antibody Discovery Market Share (%) - by Services (2022 and 2030)
Figure 14. Phage Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hybridoma: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Transgenic Animal: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Yeast Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Single Cell: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Europe Antibody Discovery Market Share (%) - by End User (2022 and 2030)
Figure 20. Pharmaceutical and Biotechnology Companies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Research Laboratories: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Europe: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
Figure 24. Europe: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 25. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 26. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 27. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 29. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 31. Growth Strategies in the Antibody Discovery Market